| Annual Financials | 2023 | 2024 | TTM |
Revenue  | 560 | 738 | 751 |
| Expenses | 337 | 454 | 469 |
| EBITDA | 223 | 284 | 282 |
| Operating Profit % | 39 % | 37 % | 36 % |
| Depreciation | 2 | 5 | 8 |
| Interest | 0 | 4 | 5 |
| Profit Before Tax | 219 | 247 | 270 |
| Tax | 54 | 66 | 70 |
| Net Profit | 165 | 181 | 200 |
| EPS in ₹ | 71.60 | 78.59 | 86.80 |
Sanofi Consumer Healthcare
Sanofi Consumer Healthcare
5,298.90
+505.00
(10.53%)
There are 5 new updates from the company16 hours ago
Show All
Market Cap
12,203.70 Cr
EPS
78.59
PE Ratio
58.78
Dividend Yield
1.15 %
Industry
Healthcare52 Week High
5,894.50
52 Week Low
4,211.55
PB Ratio
40.36
Debt to Equity
0.04
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
Company News
View All News
Sanofi Consumer Healthcare India Limited appointed Mr. Narahari Naidu as Chief Financial Officer effective August 4th, 2025, for a six-month term. The appointment was approved by the Board of Directors based on recommendations from the Nomination and Remuneration Committee and in consultation with the Audit Committee. Naidu brings over 14 years of experience across healthcare/pharmaceuticals, manufacturing, and consulting sectors, with expertise in Finance & Accounts, Procurement, Investor Relations, Mergers & Acquisitions, Banking & Treasury, and IPO management. He previously served as Group CFO for entities operating across India, UK and USA.
Sanofi Consumer Healthcare India Limited reported revenue from operations of ₹2,209 million for the quarter ended June 30, 2025, representing a 28% increase from ₹1,723 million in the same quarter last year. Net profit rose 21% to ₹607 million compared to ₹290 million in the previous year quarter. For the half-year period, revenue remained flat at ₹3,935 million versus ₹3,939 million, while profit increased to ₹1,107 million from ₹917 million. The company recorded an exceptional gain of ₹66 million from reversing excess demerger-related provisions. Basic and diluted earnings per share for the quarter stood at ₹26.36 compared to ₹12.58 in the prior year. The company successfully relaunched Combiflam Suspension during the quarter and continues efforts to bring back other recalled products to market.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,627.20 | #1 3,90,419.79 | 34.32 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 39.82 | |
6,398.00 | 1,69,846.80 | 78.70 | 9,712.00 | 0.89 | 2,191 | 23.05 | 40.60 | |
3,601.10 | 1,21,877.59 | 60.55 | 11,539.40 | 6.99 | 1,911 | 19.91 | 59.55 | |
1,494.00 | 1,20,671.55 | 22.70 | 28,409.50 | 7.12 | 5,291 | 9.88 | 51.08 | |
2,594.00 | 1,07,061.84 | 57.39 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 61.34 | |
1,207.20 | 1,00,749.42 | #1 18.00 | 33,741.20 | 16.73 | 5,725 | 1.26 | 37.38 | |
955.80 | 96,175.84 | 20.78 | 23,511.00 | 13.82 | 4,615 | -0.19 | 44.94 | |
1,867.00 | 85,265.04 | 26.48 | 22,909.50 | 19.94 | 3,306 | #1 112.49 | 40.26 | |
33,545.00 | 71,280.78 | 51.12 | 6,684.70 | 10.80 | 1,414 | 27.83 | 50.92 | |
1,071.20 | 62,215.47 | 18.34 | 31,378.10 | 17.55 | 3,366 | -10.24 | 39.98 |
Forecast
Actual
Growth Rate
Revenue Growth
31.81 %
Net Income Growth
9.76 %
Cash Flow Change
1,09,850.00 %
ROE
-16.53 %
ROCE
-18.07 %
EBITDA Margin (Avg.)
-
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 |
| Total Assets | 345 | 431 |
| Fixed Assets | 5 | 29 |
| Current Assets | 335 | 392 |
| Capital Work in Progress | 3 | 1 |
| Investments | 0 | 0 |
| Other Assets | 338 | 402 |
| Total Liabilities | 345 | 431 |
| Current Liabilities | 130 | 131 |
| Non Current Liabilities | 8 | 28 |
| Total Equity | 208 | 273 |
| Reserve & Surplus | 183 | 250 |
| Share Capital | 2 | 23 |
Cash Flow
| Cash Flow | 2023 | 2024 |
| Net Cash Flow | 2 | 325 |
| Investing Activities | 0 | 2 |
| Operating Activities | -0 | 439 |
| Financing Activities | 2 | -116 |
Share Holding
| % Holding | Jun 2024 | Sept 2024 | Oct 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 60.40 % | 60.40 % | 60.40 % | 60.40 % | 60.40 % | 71.27 % |
| FIIs | 0.00 % | 5.22 % | 4.87 % | 4.42 % | 4.53 % | 3.24 % |
| DIIs | 20.87 % | 24.03 % | 24.51 % | 25.35 % | 25.48 % | 16.89 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 7.71 % | 7.53 % | 7.41 % | 7.01 % | 6.58 % | 6.30 % |
| Others | 11.03 % | 2.83 % | 2.82 % | 2.83 % | 3.01 % | 2.30 % |
| No of Share Holders | 61,091 | 61,091 | 57,598 | 55,734 | 51,859 | 49,632 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 55 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.14 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 04 Aug 2025 |  Quarterly Result Announcement | NA | 04 Aug 2025 | 4,968.40 | 4,864.10 |
| 05 May 2025 |  Annual General Meeting | NA | 05 May 2025 | 4,750.15 | 4,938.45 |
| 02 May 2025 | Quarterly Result Announcement | NA | 02 May 2025 | 4,940.10 | 4,942.35 |
| 17 Apr 2025 |  Dividend | ₹ 55.00 /share | 17 Apr 2025 | 4,743.70 | 4,984.00 |
| 20 Feb 2025 | Quarterly Result Announcement | NA | 20 Feb 2025 | 4,714.65 | 4,743.70 |
| 12 Nov 2024 | Quarterly Result Announcement | NA | 12 Nov 2024 | 4,864.05 | 4,911.45 |
Announcements
Appointment Of Chief Financial Officer - Key Managerial Personnel
16 hours ago
16 hours agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release17 hours ago
17 hours agoOutcome Of Board Meeting Held On Monday 4Th August 202517 hours ago
17 hours agoBoard Meeting Outcome for Outcome Of Board Meeting Held On Monday 4Th August 202517 hours ago
17 hours agoBoard Meeting Outcome for Outcome Of Board Meeting Held On Monday 4Th August 202517 hours ago
17 hours agoBoard Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 20257 days ago
7 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Disclosure Under Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Jun 13, 2025
Jun 13, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 13, 2025
Jun 13, 2025Post-Offer AdvertisementMay 24, 2025
May 24, 2025Updates on Open OfferMay 10, 2025
May 10, 2025Updates on Open OfferMay 09, 2025
May 09, 2025Updates on Open OfferMay 08, 2025
May 08, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportMay 07, 2025
May 07, 2025Updates on Open OfferMay 07, 2025
May 07, 2025Updates on Open OfferMay 06, 2025
May 06, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 03, 2025
May 03, 2025Updates on Open OfferMay 03, 2025
May 03, 2025Updates on Open OfferMay 03, 2025
May 03, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 02, 2025
May 02, 2025Board Meeting Outcome For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St March 2025May 02, 2025
May 02, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday 2Nd May 2025May 02, 2025
May 02, 2025Updates on Open OfferMay 02, 2025
May 02, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 01, 2025
May 01, 2025Updates on Open OfferApr 30, 2025
Apr 30, 2025Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St March 2025Apr 25, 2025
Apr 25, 2025Updates on Open OfferApr 24, 2025
Apr 24, 2025Corrigendum To The Annual Report For Financial Year 2024Apr 23, 2025
Apr 23, 2025Reg. 34 (1) Annual Report.Apr 23, 2025
Apr 23, 2025Letter of OfferApr 16, 2025
Apr 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Apr 15, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 13, 2025
Apr 13, 2025Business Responsibility and Sustainability Reporting (BRSR)Apr 12, 2025
Apr 12, 2025Shareholder Meeting - AGM On May 5 2025Apr 12, 2025
Apr 12, 2025Reg. 34 (1) Annual Report.Apr 12, 2025
Apr 12, 2025Newspaper Publication Of Recommendations By The Committee Of Independent Directors Pursuant To Regulation 26(7) Of The SEBI (SAST) Regulations 2011 Is Enclosed.Apr 11, 2025
Apr 11, 2025Announcement under Regulation 30 (LODR)-Open Offer - UpdatesApr 10, 2025
Apr 10, 2025Intimation For Change In Record Date For DividendApr 09, 2025
Apr 09, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 04, 2025
Apr 04, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Apr 04, 2025
Apr 04, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorApr 04, 2025
Apr 04, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 30, 2025
Mar 30, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 30, 2025
Mar 30, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Intimation Of Second (2Nd) Annual General Meeting Of The CompanyMar 27, 2025
Mar 27, 2025Newspaper Publication - Annual General Meeting Through Video Conferencing FacilityMar 25, 2025
Mar 25, 2025Determination Of Book Closure And Record Dates For DividendMar 05, 2025
Mar 05, 2025Determination Of Book Closure And Record Date For DividendMar 04, 2025
Mar 04, 2025Technical Indicators
RSI(14)
Neutral 34.91
ATR(14)
Volatile 164.73
STOCH(9,6)
Neutral 21.03
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -33.74
ADX(14)
Weak Trend 19.85
UO(9)
Bearish 40.25
ROC(12)
Downtrend And Accelerating -6.51
WillR(14)
Oversold -85.92
Mutual Fund Holdings
UTI Dividend Yield Fund Direct-Growth 
Baroda BNP Paribas Value Fund Direct - Growth 
Nippon India Multi Asset Allocation Fund Direct - Growth 
LIC MF Large & Mid Cap Fund Direct-Growth 
ICICI Prudential Smallcap Fund Direct Plan-Growth 
Bajaj Finserv Flexi Cap Fund Direct-Growth 
Aditya Birla Sun Life Large Cap Direct Fund-Growth 
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
Angel One Nifty Total Market Index Fund Direct - Growth 
Bandhan BSE Healthcare Index Fund Direct-Growth 
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct - Growth 
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
